We have developed a web tool, PupaSNP, for high-throughput search of SNPs with potential phenotypic effect. PupaSNP inputs lists of genes (or generates them from chromosomal coordinates) and retrieves SNPs that could affect to conserved regions that the cellular machinery uses for the correct processing of genes (intron/exon boundaries or The PupaSNP web interface is accessible through
INTRODUCTION
Single nucleotide polymorphisms (SNPs) are the simplest and most frequent type of DNA sequence variation among individuals and they represent one of the most powerful tools for the analysis of genomes [1] . Due to their widespread distribution, SNPs are particularly valuable as genetic markers in the search for disease susceptibility genes, drug responsedetermining genes, etc. In the past decades, linkage analysis has been very successful in the identification of genes responsible for mendelian diseases. Nevertheless, direct application of linkage analysis to the case of complex diseases, in which several genes with weake r genotype-phenotype correlations are involved, has resulted in a more modest success [2] . Now, it is believed that improved genotyping methods in combination with the proper design strategies could bring the genetic of complex diseases to a point of success comparable to where mendelian genetics now firmly resides [3] .
There are examples documented in which alleles of more than one single gene are contributing to the same disease. It is generally believed that multigenecity reflects disruptions in proteins that participate in a protein complex or a in a pathway [4] . Typically, SNPs have been used as markers, that is, the real determinant of the disease was not the SNP itself but some other mutation in linkage disequilibria with it.
The use of functional SNPs could be an important factor for increasing significantly the sensitivity of association tests. In fact, several complex genetic disorders such as Alzheimer disease [5] or Crohn disease [6] have been associated with functional SNPs, lending credence to strategies giving priority to candidate markers based upon predictable function.
The last build of NCBI's dbSNP (http://www.ncbi.nlm.nih.gov/SNP/snp_summary.cgi) contains 5,772,564 SNPs, with 2,356,957 of them validated. This means that human variation has been screened to an average resolution of one SNP each 566 nucleotides.
There is also curated information on SNPs in HGVbase [7] . These figures suggest that the possibility of finding the real determinant of the disease among the characterized SNPs can be seriously considered. Actually, dbSNP build 117 contains 24,483 SNPs located in coding regions that produce amino acid change, affecting a total of 9791 different genes.
Several estimations suggest that, in the average, only 20% of them could damage the protein [8] . Much attention has been focused on the possible phenotypic effect of SNPs that 3 cause amino acid changes. The volume of available information together with the development of more sophisticated methods of protein structure prediction has led to different attempts of relating the effect of amino acid changes to structural distortions and, consequently possible phenotypic effect. Following this, two main different approaches have been taken: on one hand is the study of conservation of residues in homologous proteins [9] including more sophisticated approaches taking into account the phylogenetic history [10] and, on the other hand, there is the study of changes in the stability [11, 12] and other properties of the protein due to changes of amino acids [8, 13] .
Nevertheless, there are different ways by which the functionality of a gene product can be affected without requiring a punctual amino acid change in the protein. There is an increasing evidence that many human disease genes harbour exonic or non-coding mutations that affect pre-mRNA splicing [14] . Alternative splicing produced by mutations in intron/exon junctions, or in distinct binding motifs, such as Exonic Splicing Enhancers (ESE), to which different proteins involved in splicing bind, is in the base of different diseases. Actually, it has been estimated that 15% of point mutations that result in human genetic diseases cause RNA splicing defects [15] . For example, a silent mutation in exon 14 of the APC gene is associated with exon skipping in a Familial Adenomatous Polyposis (FAP) family [16] , and there are many more examples (see table 2 in [14] ). Also, alterations in the level of expression of the gene products can cause diseases. There are different SNPs associated to alterations in gene expression [17] and, in some cases, it is known they are altering some regulatory sequence motif. For example, a regulatory polymorphism in the programmed cell death 1 gene (PDCD1) , which alters a binding site for the runt-related transcription factor 1 (RUNX1) located in an intronic enhancer, is associated with susceptibility to systemic lupus erythematosus in humans [18] . It has also been reported that polymorphisms in the gelatinase A promoter region are associated with diminished transcriptional response to estrogen and genetic fitness [19] . A recent largescale screening over a set of 16 chromosomes, found a SNPs in the promoters regions of a 35% of the genes and experimental evidence suggested that around a third of promoter variants may alter gene expression to a functionally relevant extent [20] . Therefore, the inclusion of other possible causes of loss of functionality in gene products, beyond the simple estimation of the possible phenotypic effect of an amino acid change, increases 4 considerably the number of SNPs with potential phenotypic effect to be considered for the design of experiments.
Classical linkage statistical tests needs of a large number of cases if the number of genes to test is high. It has only recently being recognized that r eliable identification of genetic variants that affect gene regulation is still a challenge in genomics and is expected to have an important role in the molecular characterization of complex traits [21] . Another important consideration when analysing multigenic traits is the available information on the genes. Information allows a more targeted approach, by initially focusing on genes whose functionality is related with the disease studied. . This is a tool that retrieves all the SNPs present in a set of genes of interest that potentially can affect to the functionality of the gene product. This list is combined with functional information obtained from Gene Ontology annotations [22] .
Genes can be directly retrieved from genomic locations or, alternatively, can be taken from a list provided by the user. This correspond to two typical problems: a) traits mapped into a given chromosomal region or b) traits associated to a given class of genes (e.g. a signalling pathway, etc). Genome coordinates of genes and SNPs are taken from the Ensembl annotation [23] .
METHODS

Finding SNPs with potential phenotypic effect
PupaSNP operates with a collection of entries of dbSNP mapped to the Golden Path genome assembly, as implemented in human section of Ensembl (http://www.ensembl.org).
As previously mentioned, PupaSNP uses a list of genes and generates a report in which all the SNPs with possible phenotypic effect are listed. The genes can be selected directly by 5 their location in a region of the genome, or just provided as a list (e.g., genes belonging to a given pathway, involved in a particular biological function, etc). Genomic regions can be selected either by defining a range of chromosome coordinates or by directly choosing the cytoband of interest. The engine finds all the genes located within the specified region as well as their promoter regions using Ensembl APIs. In the case of a user-defined list, Ensembl is used to extract their complete intro/exon structure as well as the promoter regions.
The potential effects on the phenotype taken into account are both at transcriptional and gene product levels. These include alterations in: a) transcription factor binding sites, b) intron/exon border consensus sequences c) ESE sequences, which are the binding sites for specific serine/arginine-rich (SR) proteins involved in the splicing machinery [24, 25] and d) the exons that cause an amino acid change. Additionally, the gene ontology terms [22] associated to the genes can be obtained. This is very useful in the case of looking for genes in a chromosomal region, because it can help to discard genes definitively not involved in the disease studied, based on the annotations.
Transcription factor binding sites
In the search for SNPs with potential phenotypic effect, 10,000 bp upstream the genes, belonging to the promoter region of each gene in the list, are scanned for the presence of possible transcription factor binding sites (TFBSs). Program Match™ [26] , version 1.10, from the Transfac® database [27] , version professional 7.3, was used for this purpose.
SNPs located within these motifs are considered to have a putative phenotypic effect in the expression of the gene. The options used for the program Match TM were: a) group of matrices: vertebrates, b) use high quality matrices only and c) cut-off selection for ma trix group: to minimize false positives. This cut-off is obtained by exploring the third exon sequences with the weight matrices and chosen to reduce the number of random putative sites found by the program [26] .
Although the scan is done in a region 10,000 bp upstream the start of the gene, the number of base to be taken into account in the study is customisable. Obviously, the closer to the start of the gene the more likely the binding site is authentic.
Intron-exon boundaries
Ensembl APIs were used to extract the intron/exon organization of the genes and the corresponding sequences. The two conserved nucleotides at each side of the splicing point, that constitute the splicing signal [14] , were then located and all the SNPs altering these signals are recorded.
Exonic splicing enhancers (ESE)
Mutations that inactivate or activate an exonic splicing enhancer (ESE) sequences may result in exon skipping, malformation, etc. ESEs also appear to be important in exons that normally undergo alternative splicing. Different classes of ESE consensus motifs have been described, but they are not always easily identified. We have developed a script that scan into exon sequences to identify putative ESEs responsive to the human SR proteins SF2/ASF, SC35, SRp40 and SRp55, by using the weight matrices available for them [28] .
A score is obtained, related to the likelihood of the site found is a real ESE. Only ESE sites with scores over the threshold (see [28] and http://exon.cshl.org/ESE/ESEmatrix.html for details) are taken into account in the analysis. Threshold values, above which a score for a given sequence is considered to be significant, are set as the median of the highest score for each sequence in a set of 30 randomly-chosen 20-nt sequences (from the starting pool used for functional assays for ESE identification, see http://exon.cshl.org/ESE/ESEmatrix.html).
If a SNP disrupts one of these sequences, the new score, corresponding to the mutated sequence is also calculated. Strong differences between both score values suggest more drastic effects caused by the SNP.
Changes at amino acid level and functional implications
SNPs that result in a change of amino acid are likely to cause some phenotypic effect and, In this way the identification of common parent functions or processes is easier.
In this way, the consideration of the SNPs in a functional context can help to understand the potential biological implications of the SNPs and genes studied.
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RESULTS
SNPs with possible phenotypic effect
We analyzed a total of 24,037 human genes corresponding to the annotations in Ensembl The four bases conserved that define intron-exon boundaries were mutated by 844 SNPs, affecting to a total of 598 genes.
Over 8 millions of ESE motifs were found, covering all the genes studied. A total number of 138,746 SNPs were found to be disrupting ESE sequences. These SNPs were affecting to a total of 17,312 genes.
These results suggest that, in the search for SNPs with potential phenotypic effects, regulatory SNPS or SNPs affecting to the splicing should not be neglected.
The web interface
Input data
PupaSNP has been designed for high throughput screening of functional SNPs. Thus, the input consist of a list of genes. The list can directly be provided as a collection of gene identifiers (Ensembl IDs, or external ID, which include GenBank, Swissprot/TrEMBL and other gene Ids supported by Ensembl) or can be specified by means of a chromosomal location (cytobands or chromosomal coordinates). In the last case, PupaSNP extract all the genes contained in the specified location. Ensembl coordinates are used to extract the genes. Only Ensembl annotated genes, but not predictions, are extracted.
User-defined SNPs
Alternatively, the user can input SNPs not in the database in a very straightforward manner Figure A1 (additional information) shows the web interface, available at http://pupas.bioinfo.cnio.es/. Lists of genes can be defined by chromosome position that can be specified by means of cytoband units or in absolute chromosomal position (as mapped in the corresponding Ensembl assembly). The upstream region makes reference to the number of bases upstream in which TFBSs will be searched for (with a upper limit of 10,000 bp). Also, lists of genes can be uploaded or just pasted in the box. PupaSNP finds all the SNPs mapping in locations that might cause a loss of functionality in the genes.
The web interface
Functional information for the genes can be obtained from OMIM and from Gene
Ontology. Also information on homologous genes can be retrieved. Finally, SNPs does not need to be annotated in the genome to be included in the query tool. The user can specify a list of SNPs by giving them using a gene as reference. In that way the use of absolute coordinates, which can easily change between assembly versions is avoided in favour of the use of coordinates relative to genes, which tend to be more stable. Figure   1C is specially interesting because it shows how the scores obtained by the motif scanning method can be used to assess the possible impact of the polymorphism in the recognition of the ESE motif by the cellular machinery.
Both, the SNPs and the genes found, are linked to the Ensembl Genome Browser.
Experimental validation
Validation status of the SNPs is, in some cases, a much more important factor for its Multigenecity is generally associated to disruptions in proteins that participate in a protein complex or a in a pathway [4] . The inclusion in PupaSNP of information regarding the participation of genes in signalling cascades or in pathways or in protein complexes will be considered in the next future. Databases containing protein interaction data, such as DIP or BIND (see http://www.hgmp.mrc.ac.uk/GenomeWeb/prot-interaction.html) can be an important source of information to be considered in the search for SNPs affecting to multigentic traits.
Despite PupaSNP is more focused on SNPs with possible effects at transcriptional level, the inc lusion of an algorithm for improving the predictions of the effect of SNPs in the proteins, such as FoldX [12] , would provide, within the same framework, both types of results.
Minimum SNP set selection allows the user to optimize the number of SNPs required to represent haplotype diversity, thus reducing the cost of genotyping by assaying the minimum number of SNPs required. The inclusion of information on LD or on haplotype blocks can assist in a more efficient selection of SNPs. Some programs, such as HapScope [34] include information on haplotypes and use them to select minimum subsets of SNPs.
Another important issue is the reliability of the SNPs. As previously mentioned, only a 40% of the SNPs in dbSNP have been validated, and only for a 5% population frequencies are available. This means that most of the SNPs found in any kind of selection will lack information on its possible presence in the population of interest as a manageable polymorphism. Despite our results suggests a high rate of authenticity, even for the SNPs labeled as "no info", they must be taken carefully, and cannot be directly extrapolated to the entire database. As population frequencies are included in the database, these data could be of interest to be used as part of the selection process of SNPs PupaSNP will be the tool used in first step of the pipeline for the study of polymorphisms in the Spanish National Genotyping Center (CNG). For this reason it has been developed to cope with high throughput experimental designs. PupaSNP inputs lists of genes (or generates them from chromosomal coordinates) and provides results which integrate all the information available as well as obtained by means of predictions on SNPs with possible functional consequences.
